SZELA MARY T (CEO and President) sold 2.6% of their position (20.30K shares) of TRISALUS LIFE SCIENCES, INC. on the open market
Open‑market sale worth $79.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/20/2026ACC: 0001628280-26-020186
DirectorOfficer· CEO and President
Since Feb 2026
-20.30K
Net shares
Net seller
$79.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
20.30K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−4.36K
Price / share
$4.13
Trade value
$18K
% of position
0.6%
3/11/2026
773.29K→768.93K
Common Stock
Direct
Shares
−15.94K
Price / share
$3.85
Trade value
$61.38K
% of position
2.1%
3/17/2026
768.93K→752.99K
Total
Net shares
−20.30K
Net value
-$79.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2026 | S · Sale | −4.36K | $4.13 | $18K | 0.6% | 773.29K | 768.93K |
| Common Stock Direct | 3/17/2026 | S · Sale | −15.94K | $3.85 | $61.38K | 2.1% | 768.93K | 752.99K |
| Total | −20.30K | -$79.38K | ||||||
Derivative Transactions0
No derivative transactions reported